2/6/2024 -- $9 million NIH grant advances drug to treat nicotine addiction. Camino Pharma Press Release
12/7/2023 -- Camino Pharma receives $1.97M Small Business Innovation Research (SBIR) Grant from the National Institute of Alcohol Abuse and Alcoholism. Camino Pharma Press Release
8/25/2021 -- Camino Pharma initiates Phase 1 study of SBP-9330 in development for the treatment of tobacco use disorder. Camino Pharma Press Release
9/16/2020 -- $11.4 million NIH grant advances drug to treat nicotine addiction. Funding awarded to scientists at Sanford Burnham Prebys, Camino Pharma and UC San Diego propels drug candidate through first-in-human studies. Camino Pharma Press Release
6/30/2020 -- Camino Pharma receives $920K Small Business Innovation Research (SBIR) grant from the National Institute of Mental Health. New class of drugs focuses on treating major depression. Camino Pharma Press Release
9/27/2017 -- Camino Pharma Co-founder Receives $10.8 Million Grant for Development of Potential Drug for Cocaine and Nicotine Addiction. Camino Pharma Press Release
9/26/2017 -- SBP Scientist Receives $10.8 Million Grant to Advance Potential Drug for Substance Abuse. New class of drug may help treat cocaine and nicotine addiction. SBP Press Release
9/26/2017 -- San Diego scientist gets $10.8 million for substance abuse drug. The San Diego Union-Tribune
9/26/2017 -- Sanford Burnham Prebys Testing Drugs to Treat Cocaine, Nicotine Addictions. Times of San Diego